COMP <GO>
RPRX vs ZTS // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Royalty Pharma plc (Class A) (NASDAQ) VS. Zoetis Inc. (NYSE) • 15-METRIC TALLY: RPRX 6
— ZTS 6
■ METRIC PARITY
LAST: $67.18 (+1.90%) • MKT CAP: $38.63B
options-implied-move
—
LAST: $79.72 (+1.17%) • MKT CAP: $32.94B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RPRX VS. ZTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RPRX | ZTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 71.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.00% | 25.70% | -18.70 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.8x | 10.3x | +17.50 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 6.29% | 7.01% | -0.72 | ZTS | /fcf-yield <GO> |
| Operating Margin | 65.60% | 34.40% | +31.20 | RPRX | /operating-margins <GO> |
| Net Profit Margin | 32.40% | 28.20% | +4.20 | RPRX | /net-margins <GO> |
| Revenue Growth (YoY) | 5.10% | 2.30% | +2.80 | RPRX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.90 | 4.53 | -1.63 | ZTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | RPRX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.0 | 59.6 | +12.40 | RPRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.99 | -0.05 | ZTS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.8x | 11.3x | +34.50 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $38.63B | $32.94B | $5.69B | RPRX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RPRX REV | ZTS REV | RPRX GROSS % | ZTS GROSS % | RPRX FCF | ZTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.38B | $9.47B | — | 71.8% | $2.38B | $2.28B |
| FY 2024 | $2.26B | $9.26B | — | 70.6% | $2.67B | $2.30B |
| FY 2023 | $2.35B | $8.54B | — | — | $2.88B | $1.97B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RPRX // BETA 0.94
ZTS // BETA 0.99